Organic Listings | 1st Page Keywords | Avg Pos | Pos Trend | Est.Traffic | Traffic Value | |
---|---|---|---|---|---|---|
SEC Filings | Atara Biotherapeutics http://investors.atarabio.com/Results 1 - 10 of 542 - View H | 2 | 17 | 24200 | $0 | ||
Keyword | Position | Trend | Search Vol | CPC | ||
sec filings | 15 | 12,100 | $6.67 | |||
sec-filings | 19 | 12,100 | $6.67 | |||
Company - Atara Biotherapeutics http://www.atarabio.com/companAtara Biotherapeutics (Nasdaq: | 2 | 16 ( 7 ) | 620 | $0 | ||
Keyword | Position | Trend | Search Vol | CPC | ||
biotherapeutics | 16 | 590 | N /A | |||
biotheraputics | 9 | 30 | $1.72 | |||
PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. T-cell immunotherapy. Epstein-Barr virus cancer. Post-transplant lymphoma. Contact us to learn more. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. Contact us to learn more. T-cell immunotherapy. Post-transplant lymphoma. Epstein-Barr virus cancer. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. Post-transplant lymphoma. T-cell immunotherapy. Epstein-Barr virus cancer. Contact us to learn more. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. Contact us to learn more. Post-transplant lymphoma. Epstein-Barr virus cancer. T-cell immunotherapy. www.atarabio.com/tabelecleucel | |||
PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. T-cell immunotherapy. Post-transplant lymphoma. Epstein-Barr virus cancer. Contact us to learn more. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. T-cell immunotherapy. Contact us to learn more. Post-transplant lymphoma. Epstein-Barr virus cancer. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. Contact us to learn more. T-cell immunotherapy. Epstein-Barr virus cancer. Post-transplant lymphoma. www.atarabio.com/tabelecleucel PTLD cancer after transplant - Atara Biotherapeutics Phase 3 clinical studies for EBV+ PTLD after bone marrow & organ transplants. Epstein-Barr virus cancer. T-cell immunotherapy. Post-transplant lymphoma. Contact us to learn more. www.atarabio.com/tabelecleucel | |||